INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 131 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $48,979 | -36.4% | 61,827 | +25.3% | 0.00% | – |
| Q4 2022 | $76,966 | +113.8% | 49,337 | +134.3% | 0.00% | – |
| Q3 2022 | $36,000 | -92.5% | 21,056 | -83.7% | 0.00% | – |
| Q1 2019 | $482,000 | -2.6% | 129,102 | +4.3% | 0.00% | -100.0% |
| Q4 2018 | $495,000 | -62.2% | 123,817 | -17.7% | 0.00% | -50.0% |
| Q1 2016 | $1,310,000 | +41.8% | 150,437 | +9.5% | 0.00% | +100.0% |
| Q4 2015 | $924,000 | – | 137,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |